COMPARISON OF BUSULFAN-BASED AND TREOSULFAN-BASED HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Koh, Kyung-Nam [1 ]
Koh, Young Kwon [2 ]
Kang, Aejin [1 ]
Kim, Ji Young [1 ]
Yun, Su Hyun [1 ]
Kang, Sung Han [1 ]
Kim, Hyery [1 ]
Im, Ho Joon [1 ]
机构：
[1] Asan Med Ctr Childrens Hosp, Seoul, South Korea
[2] Chosun Univ, Gwangju, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P675
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [31] High-dose chemotherapy and autologous blood stem cell transplantation in children with metastatic neuroblastoma
    Kai, T
    Ishii, E
    Matsuzaki, A
    Inaba, S
    Suita, S
    Ueda, K
    ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 54 - 60
  • [32] Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
    Desai, A. V.
    Heneghan, M. B.
    Li, Y.
    Bunin, N. J.
    Grupp, S. A.
    Bagatell, R.
    Seif, A. E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1204 - 1210
  • [33] Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
    A V Desai
    M B Heneghan
    Y Li
    N J Bunin
    S A Grupp
    R Bagatell
    A E Seif
    Bone Marrow Transplantation, 2016, 51 : 1204 - 1210
  • [34] The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma
    Park, Hyun Jin
    Choi, Jung Yoon
    Kim, Bo Kyung
    Hong, Kyung Taek
    Kim, Hyun-Young
    Kim, Il Han
    Cheon, Gi Jeong
    Cheon, Jung-Eun
    Park, Sung-Hye
    Kang, Hyoung Jin
    CHILDREN-BASEL, 2023, 10 (12):
  • [35] Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: Results of SMC NB-2004 study
    K W Sung
    M H Son
    S H Lee
    K H Yoo
    H H Koo
    J Y Kim
    E J Cho
    S K Lee
    Y S Choi
    D H Lim
    J-S Kim
    D W Kim
    Bone Marrow Transplantation, 2013, 48 : 68 - 73
  • [36] Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: Results of SMC NB-2004 study
    Sung, K. W.
    Son, M. H.
    Lee, S. H.
    Yoo, K. H.
    Koo, H. H.
    Kim, J. Y.
    Cho, E. J.
    Lee, S. K.
    Choi, Y. S.
    Lim, D. H.
    Kim, J-S
    Kim, D. W.
    BONE MARROW TRANSPLANTATION, 2013, 48 (01) : 68 - 73
  • [37] Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation with TTC/MEC REGIMENS ± 131I-MIBG for High-Risk Neuroblastoma
    Park, H. J.
    Choi, J. Y.
    Kang, H. J.
    Kim, B. K.
    Hong, K. T.
    Kim, H. Y.
    Kim, I. H.
    Cheon, G. J.
    Cheon, J. E.
    Park, S. H.
    Shin, H. Y.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S338 - S338
  • [38] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF HIGH-RISK PEDIATRIC RHABDOMYOSACROMA PATIENTS
    Shiriaev, S. N.
    Makarova, I. V.
    Kazantsev, I. V.
    Gevorgyan, A. G.
    Kozlov, A. V.
    Youkhta, T. V.
    Klimov, A. S.
    Shvetsov, A. N.
    Morozova, E. V.
    Zubarovskaya, L. S.
    Afanasiev, B. V.
    Safonova, S. A.
    Punanov, Y. A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 237 - 237
  • [39] Retrospective analysis of high-dose chemotherapy followed by autologous stem cell transplantation for high-risk pediatric osteosarcoma
    Uemura, Suguru
    Mori, Takeshi
    Ishiko, Shinya
    Takafuji, Satoru
    Nino, Nanako
    Yamamoto, Nobuyuki
    Hayakawa, Akira
    Nishimura, Noriyuki
    Hara, Hitomi
    Kawamoto, Teruya
    Akisue, Toshihiro
    Iijima, Kazumoto
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (04) : 337 - 343
  • [40] IS THERE A ROLE FOR HIGH-DOSE CHEMOTHERAPY (HDCT) WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) IN HIGH-RISK NEUROBLASTOMA IN RESOURCE-LIMITED SETTINGS?
    Radhakrishnan, Venkatraman
    Venkatakrishnan, Kritthivasan
    Kannan, Krishnarathinam
    Kalaiyarasi, Jayachandran Perumal
    Mehra, Nikita
    Karunakaran, Parathan
    Selvarajan, Gangothri
    Kesana, Sivasree
    Indhuja, M. V.
    Rajendaran, Akhil
    Balaji, Tk
    Srinivasan, Prasanth
    Das, Gargi
    PEDIATRIC BLOOD & CANCER, 2023, 70
12345